Publications by authors named "Bruce Cheson"

100Publications

Copanlisib in the treatment of non-Hodgkin lymphoma.

Future Oncol 2020 Sep 13;16(26):1947-1955. Epub 2020 Jul 13.

Lymphoma Research Foundation, NY 10005, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2020-0195DOI Listing
September 2020

Successful Treatment of Ocular Chronic Lymphocytic Leukemia with Ibrutinib: Case Report and Review of the Literature.

Leuk Res Rep 2020 20;14:100200. Epub 2020 Apr 20.

Department of Hematology and Oncology, MedStar Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2020.100200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265052PMC
April 2020

Management of Adverse Events From the Combination of Rituximab and Lenalidomide in the Treatment of Patients With Follicular and Low-Grade Non-Hodgkin Lymphoma.

Clin Lymphoma Myeloma Leuk 2020 Sep 20;20(9):563-571. Epub 2020 Mar 20.

Department of Medicine, Weill Medical College of Cornell University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.03.009DOI Listing
September 2020

Predicting the future for DLBCL.

Authors:
Bruce D Cheson

Blood 2020 04;135(16):1308-1309

Lymphoma Research Foundation.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2020005002DOI Listing
April 2020

Targeted Therapies in Chronic Lymphocytic Leukemia: Is 2 (or 3) Better Than 1?

Cancer J 2019 Nov/Dec;25(6):449-454

Division of Hematology-Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000410DOI Listing
August 2020

Introduction by the Guest Editor: Staying Ahead of the Rapidly Evolving World of Chronic Lymphocytic Leukemia.

Authors:
Bruce D Cheson

Cancer J 2019 Nov/Dec;25(6):373

From the Georgetown University Hospital, Lombardi Comprehensive Cancer Center, 3800 Reservoir Rd, N.W. Washington, DC 20007.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000415DOI Listing
August 2020

Targeting Biology in Non-Hodgkin Lymphoma.

Hematol Oncol Clin North Am 2019 08 7;33(4):727-738. Epub 2019 May 7.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Lombardi Comprehensive Cancer Center Podium A, 3800 Reservoir Road Northwest, Washington, DC 20007, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2019.03.006DOI Listing
August 2019

Descriptive analysis of genetic aberrations and cell of origin in Richter transformation.

Leuk Lymphoma 2019 04 11;60(4):971-979. Epub 2019 Jan 11.

f Department of Hematology and Oncology , Lombardi Comprehensive Cancer Center Medstar Georgetown University Hospital , Washington , D.C , U.S.A.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1516878DOI Listing
April 2019

Combinations or sequences of targeted agents in CLL: is the whole greater than the sum of its parts (Aristotle, 360 BC)?

Blood 2019 01 14;133(2):121-129. Epub 2018 Nov 14.

Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC; and.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-08
Publisher Site
http://dx.doi.org/10.1182/blood-2018-08-869503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265785PMC
January 2019

Determining the sequence of novel therapies in the treatment of relapsed Hodgkin's lymphoma.

Expert Rev Hematol 2018 10 5;11(10):773-780. Epub 2018 Sep 5.

a Lombardi Comprehensive Cancer Center , MedStar Georgetown University Hospital , Washington , DC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1516135DOI Listing
October 2018

Speaking volumes about volumes.

Authors:
Bruce D Cheson

Blood 2018 05;131(22):2408-2409

Lombardi Comprehensive Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-841924DOI Listing
May 2018

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

J Clin Oncol 2018 08 31;36(23):2405-2412. Epub 2018 May 31.

Ajay K. Gopal, The University of Washington; Ajay K. Gopal, Fred Hutchinson Cancer Research Center, Seattle, WA; Stephen J. Schuster, Abramson Cancer Center of the University of Pennsylvania, Philadelphia; Jing-Zhou Hou, University of Pittsburgh Medical Center; Jing-Zhou Hou, University of Pittsburgh Cancer Institute, Pittsburgh; Rajendra N. Damle, Michael Schaffer, and Sriram Balasubramanian, Janssen Research & Development, Spring House, PA; Nathan H. Fowler, The University of Texas MD Anderson Cancer Center, Houston, TX; Judith Trotman, Concord Hospital, University of Sydney, Sydney, New South Wales; Andrew Spencer, Alfred Hospital-Monash University, Melbourne, Victoria; James Morton, Haematology and Oncology Clinics of Australia, Milton, Queensland, Australia; Georg Hess, Johannes Gutenberg-University, Mainz, Germany; Abdulraheem Yacoub, Kansas University Medical Center, Kansas City, KS; Michael Lill, Cedars-Sinai Medical Center, Los Angeles, CA; Peter Martin, Weill Cornell Medical College, Cornell University, New York, NY; Umberto Vitolo, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy; John Radford, University of Manchester; John Radford, Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Wojciech Jurczak, Jagiellonian University, Kraków, Poland; Dolores Caballero, Hospital Clínico Universitario, Salamanca, Spain; Sanjay Deshpande, Gary J. Gartenberg, and Shean-Sheng Wang, Janssen Research & Development, Raritan, NJ; Jessica Vermeulen, Janssen Research & Development, Leiden, the Netherlands; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; and Gilles Salles, Hospices Civils de Lyon-Université de Lyon, Pierre-Bénite cedex, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8853DOI Listing
August 2018

Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma.

Clin Lymphoma Myeloma Leuk 2018 07 5;18(7):447-451. Epub 2018 May 5.

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650183003
Publisher Site
http://dx.doi.org/10.1016/j.clml.2018.04.008DOI Listing
July 2018

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study.

J Clin Oncol 2018 08 27;36(22):2259-2266. Epub 2018 Mar 27.

Bruce D. Cheson, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC; Neil Chua, University of Alberta, Edmonton, Alberta; Greg Dueck, British Columbia Cancer Agency, Kelowna; Laurie H. Sehn, Centre for Lymphoid Cancer, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada; Jiri Mayer, University Hospital and Masaryk University, Brno; Marek Trněný, Charles University General Hospital, Prague, Czech Republic; Kamal Bouabdallah, Centre Hospitalier Universitaire Haut-Leveque, Bordeaux; Vincent Delwail, Centre Hospitalier Universitaire de Poitiers, Poitiers; Gilles Salles, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France; Nathan Fowler, University of Texas, Houston, TX; Oliver Press, Fred Hutchinson Cancer Research Center, Seattle, WA; John G. Gribben, Queen Mary University of London, London; Anne Lennard, Newcastle University, Newcastle upon Tyne, United Kingdom; Pieternella J. Lugtenburg, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; and Günter Fingerle-Rowson, Federico Mattiello, and Andrea Knapp, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.3656
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.3656DOI Listing
August 2018

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.

J Clin Oncol 2018 03 22;36(7):697-703. Epub 2018 Jan 22.

Mazyar Shadman, Ajay K. Gopal, David G. Maloney, and Oliver W. Press, University of Washington and Fred Hutchinson Cancer Research Center; Hongli Li and Michael LeBlanc, SWOG Statistical Center, Seattle, WA; Lisa Rimsza, Mayo Clinic Arizona, Scottsdale; Catherine M. Spier, University of Arizona, Tucson, AZ; John P. Leonard, Weill Cornell Medical College, New York; Jonathan W. Friedberg, Wilmot Cancer Institute, University of Rochester, Rochester, NY; Mark S. Kaminski, University of Michigan Health System, Ann Arbor, MI; Rita M. Braziel, Oregon Health & Science University, Portland, OR; Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC; Shaker Dakhil, University of Kansas School of Medicine-Wichita, Wichita, KS; Sonali M. Smith, University of Chicago Medicine, Chicago, IL; and Richard I. Fisher, Fox Chase Cancer Center and Temple University School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.5083
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.5083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553811PMC
March 2018

PET/CT in Lymphoma: Current Overview and Future Directions.

Authors:
Bruce D Cheson

Semin Nucl Med 2018 01 2;48(1):76-81. Epub 2017 Oct 2.

Georgetown University Hospital, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00012998173008
Publisher Site
http://dx.doi.org/10.1053/j.semnuclmed.2017.09.007DOI Listing
January 2018

Impact of obinutuzumab alone and in combination for follicular lymphoma.

Blood Lymphat Cancer 2017 19;7:73-83. Epub 2017 Oct 19.

Division of Hematology-Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S114173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467363PMC
October 2017

Extended Follow-up of Patients Treated With Bendamustine for Lymphoid Malignancies.

Clin Lymphoma Myeloma Leuk 2017 10 30;17(10):637-644. Epub 2017 Jun 30.

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650173025
Publisher Site
http://dx.doi.org/10.1016/j.clml.2017.06.033DOI Listing
October 2017

What Is the Role of Chemotherapy in Patients With Chronic Lymphocytic Leukemia?

Authors:
Bruce D Cheson

Clin Lymphoma Myeloma Leuk 2017 11 12;17(11):723-727. Epub 2017 Jul 12.

Division of Hematology-Oncology, Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.023DOI Listing
November 2017

Pros and cons of rituximab maintenance in follicular lymphoma.

Cancer Treat Rev 2017 Jul 16;58:34-40. Epub 2017 Jun 16.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.05.007DOI Listing
July 2017

Letter From the Editor: The end.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Dec;14(12):942

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
December 2016

FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.

Oncology (Williston Park) 2017 01;31(1):45-9

View Article

Download full-text PDF

Source
January 2017

PI3K signaling pathway in normal B cells and indolent B-cell malignancies.

Semin Oncol 2016 Dec 17;43(6):647-654. Epub 2016 Nov 17.

Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2016.11.011DOI Listing
December 2016

Recommendations for Clinical Trial Development in Follicular Lymphoma.

J Natl Cancer Inst 2017 03 31;109(3). Epub 2016 Dec 31.

Affiliations of authors: The Ohio State University, Columbus, OH (KM); University of Rochester Medical Center, Rochester, NY (PMB); Georgetown University Hospital, Washington, DC (BDC); Division of Cancer Treatment and Diagnosis (RFL) and Coordinating Center for Clinical Trials (LB), National Cancer Institute, Bethesda, MD; Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Department of Medicine, Weil Cornell University, New York, NY (JPL); The University of Texas MD Anderson Cancer Center, Houston, TX (NF); Northwestern University, Chicago, IL (LIG); University of Iowa, Iowa City, IA (BKL); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Mayo Clinic, Rochester, MN (SMA).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059137PMC
March 2017

Ibrutinib in Waldenström's macroglobulinemia: revamping the landscape.

Lancet Oncol 2017 02 10;18(2):165-166. Epub 2016 Dec 10.

Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC 20007, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30623-4DOI Listing
February 2017

Letter From the Editor: Ode to Bob.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Nov;14(11):838

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
November 2016

Letter From the Editor: Fellowship interviews and more.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Oct;14(10):742

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
October 2016

Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study.

Leuk Lymphoma 2017 06 10;58(6):1332-1340. Epub 2016 Oct 10.

f Division of Hematology and Oncology , Georgetown University , Washington , DC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1233535DOI Listing
June 2017

Letter From the Editor: From 2003 to today.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Sep;14(9):646

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
September 2016

Letter from the editor: the campaign button.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Aug;14(8):566

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
August 2016

Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and Kwee.

Br J Haematol 2017 10 8;179(2):337-339. Epub 2016 Jul 8.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14216DOI Listing
October 2017

Letter From the Editor: When will we ever learn?

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Jul;14(7):461

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
July 2016

Letter From the Editor: When Breath Becomes Air.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Jun;14(6):382

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
June 2016

Letter From the Editor: The pedant and the scoundrel.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 May;14(5):286

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
May 2016

Speed bumps on the road to a chemotherapy-free world for lymphoma patients.

Authors:
Bruce D Cheson

Blood 2016 07 24;128(3):325-30. Epub 2016 May 24.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-04-709477DOI Listing
July 2016

Letter From the Editor: Moonshot medicine.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Apr;14(4):198

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
April 2016

(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.

Br J Haematol 2016 08 20;174(3):410-6. Epub 2016 Apr 20.

Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14071DOI Listing
August 2016

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

J Clin Oncol 2016 06 11;34(17):2020-7. Epub 2016 Apr 11.

Oliver W. Press, Fred Hutchinson Cancer Research Center, and the University of Washington; Hongli Li and Michael LeBlanc, Fred Hutchinson Cancer Research Center, Seattle, WA; Heiko Schöder, David J. Straus, Craig H. Moskowitz, and Ariela Noy, Memorial Sloan Kettering Cancer Center; John P. Leonard, Weill Cornell Medical College and New York Presbyterian Hospital, New York City; Paul M. Barr and Jonathan W. Friedberg, University of Rochester Medical Center, Rochester, NY; Lisa M. Rimsza, University of Arizona, Tucson, AZ; Nancy L. Bartlett and Brad S. Kahl, Washington University School of Medicine, St. Louis, MO; Andrew M. Evens, Tufts Medical Center; Ann S. LaCasce, Dana-Farber Cancer Institute, Boston, MA; Erik S. Mittra, Stanford University Medical Center, Stanford, CA; John W. Sweetenham, Huntsman Cancer Hospital, Salt Lake City, UT; Michelle A. Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Michael V. Knopp, The Ohio State University, Columbus; Eric D. Hsi, Cleveland Clinic Foundation; James R. Cook, Cleveland Clinic, Cleveland, OH; Mary Jo Lechowicz, Winship Cancer Institute of Emory University, Atlanta, GA; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC; Bruce D. Cheson, Georgetown University Hospital, Washington DC; and Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966513PMC
June 2016

Letter From the Editor: A thankful end of the year.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Dec;13(12):787

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
December 2015

Letter From the Editor: For what it's worth.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Nov;13(11):695

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
November 2015

Letter From the Editor: Interviewing season.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Oct;13(10):621

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
October 2015

Letter From the Editor: Doctors as writers.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Mar;14(3):143

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
March 2016

Letter From the Editor: I love boobies.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2016 Feb;14(2):72

Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
February 2016

The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia.

Ther Adv Hematol 2016 Apr 3;7(2):69-84. Epub 2016 Feb 3.

Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, 3800 Reservoir Road NW, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620715625966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802506PMC
April 2016

What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?

Expert Rev Hematol 2015 Dec 14;8(6):733-42. Epub 2015 Sep 14.

b 2 Medstar Georgetown University Hospital, Washington DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.1087844DOI Listing
December 2015

Letter From the Editor: Reflections on Lugano.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Jul;13(7):409

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
July 2015

The "ASC(ST)O" meeting.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Jun;13(6):341

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
June 2015

Letter From the Editor: The return of the emperor.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 May;13(5):271

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
May 2015

Letter From the Editor: Inside my file cabinets.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Apr;13(4):203

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
April 2015

Letter From the Editor: Lies and truth.

Authors:
Bruce D Cheson

Clin Adv Hematol Oncol 2015 Mar;13(3):140

Department of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, District of Columbia.

View Article

Download full-text PDF

Source
March 2015

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).

J Clin Oncol 2015 Nov 24;33(31):3635-40. Epub 2015 Aug 24.

John P. Leonard, Meyer Cancer Center, Weill Cornell Medical College and New York Presbyterian Hospital, New York; Myron Czuczman, Roswell Park Cancer Institute, Buffalo, NY; Sin-Ho Jung, Jeffrey Johnson, and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; Kristie A. Blum, Ohio State University Medical Center, Columbus, OH; Jeffrey K. Giguere, Greenville Community Clinical Oncology Program, Greenville, SC; and Bruce D. Cheson, Georgetown University Hospital, Washington, DC.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/08/21/JCO.2014.59
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.9258
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.9258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622102PMC
November 2015

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

Authors:
Ayalew Tefferi Hagop Kantarjian S Vincent Rajkumar Lawrence H Baker Jan L Abkowitz John W Adamson Ranjana Hira Advani James Allison Karen H Antman Robert C Bast John M Bennett Edward J Benz Nancy Berliner Joseph Bertino Ravi Bhatia Smita Bhatia Deepa Bhojwani Charles D Blanke Clara D Bloomfield Linda Bosserman Hal E Broxmeyer John C Byrd Fernando Cabanillas George Peter Canellos Bruce A Chabner Asher Chanan-Khan Bruce Cheson Bayard Clarkson Susan L Cohn Gerardo Colon-Otero Jorge Cortes Steven Coutre Massimo Cristofanilli Walter J Curran George Q Daley Daniel J DeAngelo H Joachim Deeg Lawrence H Einhorn Harry P Erba Francisco J Esteva Elihu Estey Isaiah J Fidler James Foran Stephen Forman Emil Freireich Charles Fuchs James N George Morie A Gertz Sergio Giralt Harvey Golomb Peter Greenberg Jordan Gutterman Robert I Handin Samuel Hellman Paulo Marcelo Hoff Ronald Hoffman Waun Ki Hong Mary Horowitz Gabriel N Hortobagyi Clifford Hudis Jean Pierre Issa Bruce Evan Johnson Philip W Kantoff Kenneth Kaushansky David Khayat Fadlo R Khuri Thomas J Kipps Margaret Kripke Robert A Kyle Richard A Larson Theodore S Lawrence Ross Levine Michael P Link Scott M Lippman Sagar Lonial Gary H Lyman Maurie Markman John Mendelsohn Neal J Meropol Yoav Messinger Therese M Mulvey Susan O'Brien Roman Perez-Soler Raphael Pollock Josef Prchal Oliver Press Jerald Radich Kanti Rai Saul A Rosenberg Jacob M Rowe Hope Rugo Carolyn D Runowicz Brenda M Sandmaier Alan Saven Andrew I Schafer Charles Schiffer Mikkael A Sekeres Richard T Silver Lillian L Siu David P Steensma F Marc Stewart Wendy Stock Richard Stone Rainer Storb Louise C Strong Martin S Tallman Michael Thompson Naoto T Ueno Richard A Van Etten Julie M Vose Peter H Wiernik Eric P Winer Anas Younes Andrew D Zelenetz Charles A LeMaistre

Mayo Clin Proc 2015 Aug 23;90(8):996-1000. Epub 2015 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mayocp.2015.06.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365030PMC
August 2015

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

J Clin Oncol 2015 Jul 15;33(21):2399-404. Epub 2015 Jun 15.

Paul M. Barr and Jonathan W. Friedberg, University of Rochester, Rochester; Steven M. Horwitz, Memorial Sloan Kettering Cancer Center, New York, NY; Hongli Li and Michael LeBlanc, SWOG Statistical Office, Seattle, WA; Catherine Spier, University of Arizona College of Medicine, Tucson, AZ; Daruka Mahadevan, Mansoor Ul Haq, and Bryan D. Huber, University of Tennessee Health Sciences Center, Memphis, TN; Christopher R. Flowers, Emory University, Atlanta, GA; Nina D. Wagner-Johnston and Nancy L. Bartlett, Washington University School of Medicine, St. Louis, MO; Richard I. Fisher, Temple University, Philadelphia, PA; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; Sonali M. Smith, The University of Chicago, Chicago, IL; and Brad S. Kahl, University of Wisconsin, Madison, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.6327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500834PMC
July 2015